
{
    "credit": [
        {
            "email": "frank.bellivier@inserm.fr",
            "name": "Frank Bellivier",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        }
    ],
    "labels": {
        "topic": [
            {
                "term": "Medical imaging",
                "uri": "http://edamontology.org/topic_3384"
            },
            {
                "term": "Psychiatry",
                "uri": "http://edamontology.org/topic_3419"
            },
            {
                "term": "Genomics",
                "uri": "http://edamontology.org/topic_0622"
            }
        ]
    },
    "link": [
        {
            "type": "Other",
            "url": "https://rlink.eu.com/"
        }
    ],
    "publication": [
        {
            "doi": "10.1186/S40345-019-0156-X",
            "pmcid": "PMC6760458",
            "pmid": "31552554"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:R-LiNK",
        "biotoolsID": "R-LiNK",
        "description": "> CORRECT NAME OF TOOL COULD ALSO BE 'Response Lithium Network' | Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders | Optimizing response to lithium treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative | R-Link is a multinational study funded by the European Unionâ€™s Horizon 2020 Research and Innovation programme. R-Link involves eight European countries including France, United Kingdom, Denmark, Spain, Norway, Sweden, Germany and Italy",
        "homepage": "http://www.r-link.eu.com/",
        "name": "R-LiNK"
    }
}